These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 8552202)
1. DNA index as prognostic factor in breast cancer. Rzymowska J; Skierski J; Kurylcio L; Dyrda Z Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306 [TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211 [TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of flow cytometry for metastatic potential in breast cancer. Schmidt H; Wei JP; Yeh KA Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212 [TBL] [Abstract][Full Text] [Related]
9. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters]. Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208 [TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Beerman H; Smit VT; Kluin PM; Bonsing BA; Hermans J; Cornelisse CJ Cytometry; 1991; 12(2):147-54. PubMed ID: 1646701 [TBL] [Abstract][Full Text] [Related]
12. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cells are a reliable internal standard for the flow cytometric DNA analysis of frozen malignant breast biopsies. Benn DE; Robinson BG Cytometry; 1996 Jun; 26(2):161-5. PubMed ID: 8817093 [TBL] [Abstract][Full Text] [Related]
14. Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer. Bergers E; van Diest PJ; Baak JP Cytometry; 1997 Feb; 30(1):54-60. PubMed ID: 9056743 [TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures. Spyratos F; Briffod M Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry. Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206 [TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
18. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Chen TL; Luo I; Mikhail N; Rasková J; Raska K Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometry and cytomorphology in primary resectable breast cancer. Bedrossian CW; Raber M; Barlogie B Anal Quant Cytol; 1981 Jun; 3(2):112-6. PubMed ID: 6266303 [TBL] [Abstract][Full Text] [Related]
20. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]